Global Human Antithrombin III Market Research Report 2024

Report ID: 1987436 | Published Date: Jan 2025 | No. of Page: 86 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Human Antithrombin III Market Overview
    1.1 Product Overview and Scope of Human Antithrombin III
    1.2 Human Antithrombin III Segment by Form
        1.2.1 Global Human Antithrombin III Sales Growth Rate Comparison by Form (2022-2028)
        1.2.2 Lyophilized Form
        1.2.3 Liquid Form
    1.3 Human Antithrombin III Segment by Application
        1.3.1 Global Human Antithrombin III Sales Comparison by Application: (2022-2028)
        1.3.2 Hmophilia
        1.3.3 Aplastic Anemia
        1.3.4 Heart Valve Disease
        1.3.5 Other
    1.4 Global Human Antithrombin III Market Size Estimates and Forecasts
        1.4.1 Global Human Antithrombin III Revenue 2017-2028
        1.4.2 Global Human Antithrombin III Sales 2017-2028
        1.4.3 Human Antithrombin III Market Size by Region: 2017 Versus 2021 Versus 2028
2 Human Antithrombin III Market Competition by Manufacturers
    2.1 Global Human Antithrombin III Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Human Antithrombin III Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Human Antithrombin III Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Human Antithrombin III Manufacturing Sites, Area Served, Product Type
    2.5 Human Antithrombin III Market Competitive Situation and Trends
        2.5.1 Human Antithrombin III Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Human Antithrombin III Players Market Share by Revenue
        2.5.3 Global Human Antithrombin III Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Antithrombin III Retrospective Market Scenario by Region
    3.1 Global Human Antithrombin III Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Human Antithrombin III Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Human Antithrombin III Market Facts & Figures by Country
        3.3.1 North America Human Antithrombin III Sales by Country
        3.3.2 North America Human Antithrombin III Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Human Antithrombin III Market Facts & Figures by Country
        3.4.1 Europe Human Antithrombin III Sales by Country
        3.4.2 Europe Human Antithrombin III Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Human Antithrombin III Market Facts & Figures by Region
        3.5.1 Asia Pacific Human Antithrombin III Sales by Region
        3.5.2 Asia Pacific Human Antithrombin III Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Human Antithrombin III Market Facts & Figures by Country
        3.6.1 Latin America Human Antithrombin III Sales by Country
        3.6.2 Latin America Human Antithrombin III Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Human Antithrombin III Market Facts & Figures by Country
        3.7.1 Middle East and Africa Human Antithrombin III Sales by Country
        3.7.2 Middle East and Africa Human Antithrombin III Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Human Antithrombin III Historic Market Analysis by Form
    4.1 Global Human Antithrombin III Sales Market Share by Form (2017-2022)
    4.2 Global Human Antithrombin III Revenue Market Share by Form (2017-2022)
    4.3 Global Human Antithrombin III Price by Form (2017-2022)
5 Global Human Antithrombin III Historic Market Analysis by Application
    5.1 Global Human Antithrombin III Sales Market Share by Application (2017-2022)
    5.2 Global Human Antithrombin III Revenue Market Share by Application (2017-2022)
    5.3 Global Human Antithrombin III Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Grifols
        6.1.1 Grifols Corporation Information
        6.1.2 Grifols Description and Business Overview
        6.1.3 Grifols Human Antithrombin III Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Grifols Human Antithrombin III Product Portfolio
        6.1.5 Grifols Recent Developments/Updates
    6.2 Lee BioSolutions
        6.2.1 Lee BioSolutions Corporation Information
        6.2.2 Lee BioSolutions Description and Business Overview
        6.2.3 Lee BioSolutions Human Antithrombin III Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Lee BioSolutions Human Antithrombin III Product Portfolio
        6.2.5 Lee BioSolutions Recent Developments/Updates
    6.3 ATryn
        6.3.1 ATryn Corporation Information
        6.3.2 ATryn Description and Business Overview
        6.3.3 ATryn Human Antithrombin III Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 ATryn Human Antithrombin III Product Portfolio
        6.3.5 ATryn Recent Developments/Updates
    6.4 LFB
        6.4.1 LFB Corporation Information
        6.4.2 LFB Description and Business Overview
        6.4.3 LFB Human Antithrombin III Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 LFB Human Antithrombin III Product Portfolio
        6.4.5 LFB Recent Developments/Updates
    6.5 Shire
        6.5.1 Shire Corporation Information
        6.5.2 Shire Description and Business Overview
        6.5.3 Shire Human Antithrombin III Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Shire Human Antithrombin III Product Portfolio
        6.5.5 Shire Recent Developments/Updates
    6.6 CSL Limited
        6.6.1 CSL Limited Corporation Information
        6.6.2 CSL Limited Description and Business Overview
        6.6.3 CSL Limited Human Antithrombin III Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 CSL Limited Human Antithrombin III Product Portfolio
        6.6.5 CSL Limited Recent Developments/Updates
    6.7 Kedrion
        6.6.1 Kedrion Corporation Information
        6.6.2 Kedrion Description and Business Overview
        6.6.3 Kedrion Human Antithrombin III Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Kedrion Human Antithrombin III Product Portfolio
        6.7.5 Kedrion Recent Developments/Updates
    6.8 Octapharma
        6.8.1 Octapharma Corporation Information
        6.8.2 Octapharma Description and Business Overview
        6.8.3 Octapharma Human Antithrombin III Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Octapharma Human Antithrombin III Product Portfolio
        6.8.5 Octapharma Recent Developments/Updates
7 Human Antithrombin III Manufacturing Cost Analysis
    7.1 Human Antithrombin III Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Human Antithrombin III
    7.4 Human Antithrombin III Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Human Antithrombin III Distributors List
    8.3 Human Antithrombin III Customers
9 Human Antithrombin III Market Dynamics
    9.1 Human Antithrombin III Industry Trends
    9.2 Human Antithrombin III Market Drivers
    9.3 Human Antithrombin III Market Challenges
    9.4 Human Antithrombin III Market Restraints
10 Global Market Forecast
    10.1 Human Antithrombin III Market Estimates and Projections by Form
        10.1.1 Global Forecasted Sales of Human Antithrombin III by Form (2023-2028)
        10.1.2 Global Forecasted Revenue of Human Antithrombin III by Form (2023-2028)
    10.2 Human Antithrombin III Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Human Antithrombin III by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Human Antithrombin III by Application (2023-2028)
    10.3 Human Antithrombin III Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Human Antithrombin III by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Human Antithrombin III by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Human Antithrombin III Sales Growth Rate Comparison by Form (2022-2028) & (K Bottles) & (US$ Million)
    Table 2. Global Human Antithrombin III Sales Growth Rate Comparison by Application (2022-2028) & (K Bottles) & (US$ Million)
    Table 3. Global Human Antithrombin III Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Human Antithrombin III Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Human Antithrombin III Sales (K Bottles) of Key Manufacturers (2017-2022)
    Table 6. Global Human Antithrombin III Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Human Antithrombin III Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Human Antithrombin III Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Human Antithrombin III Average Price (US$/Bottle) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Human Antithrombin III Manufacturing Sites and Area Served
    Table 11. Manufacturers Human Antithrombin III Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Human Antithrombin III by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Antithrombin III as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Human Antithrombin III Sales by Region (2017-2022) & (K Bottles)
    Table 16. Global Human Antithrombin III Sales Market Share by Region (2017-2022)
    Table 17. Global Human Antithrombin III Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Human Antithrombin III Revenue Market Share by Region (2017-2022)
    Table 19. North America Human Antithrombin III Sales by Country (2017-2022) & (K Bottles)
    Table 20. North America Human Antithrombin III Sales Market Share by Country (2017-2022)
    Table 21. North America Human Antithrombin III Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Human Antithrombin III Revenue Market Share by Country (2017-2022)
    Table 23. Europe Human Antithrombin III Sales by Country (2017-2022) & (K Bottles)
    Table 24. Europe Human Antithrombin III Sales Market Share by Country (2017-2022)
    Table 25. Europe Human Antithrombin III Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Human Antithrombin III Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Human Antithrombin III Sales by Region (2017-2022) & (K Bottles)
    Table 28. Asia Pacific Human Antithrombin III Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Human Antithrombin III Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Human Antithrombin III Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Human Antithrombin III Sales by Country (2017-2022) & (K Bottles)
    Table 32. Latin America Human Antithrombin III Sales Market Share by Country (2017-2022)
    Table 33. Latin America Human Antithrombin III Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Human Antithrombin III Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Human Antithrombin III Sales by Country (2017-2022) & (K Bottles)
    Table 36. Middle East and Africa Human Antithrombin III Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Human Antithrombin III Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Human Antithrombin III Revenue Market Share by Country (2017-2022)
    Table 39. Global Human Antithrombin III Sales by Form (2017-2022) & (K Bottles)
    Table 40. Global Human Antithrombin III Sales Market Share by Form (2017-2022)
    Table 41. Global Human Antithrombin III Revenue by Form (2017-2022) & (US$ Million)
    Table 42. Global Human Antithrombin III Revenue Share by Form (2017-2022)
    Table 43. Global Human Antithrombin III Price by Form (2017-2022) & (US$/Bottle)
    Table 44. Global Human Antithrombin III Sales (K Bottles) by Application (2017-2022)
    Table 45. Global Human Antithrombin III Sales Market Share by Application (2017-2022)
    Table 46. Global Human Antithrombin III Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Human Antithrombin III Revenue Share by Application (2017-2022)
    Table 48. Global Human Antithrombin III Price by Application (2017-2022) & (US$/Bottle)
    Table 49. Grifols Corporation Information
    Table 50. Grifols Description and Business Overview
    Table 51. Grifols Human Antithrombin III Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2017-2022)
    Table 52. Grifols Human Antithrombin III Product
    Table 53. Grifols Recent Developments/Updates
    Table 54. Lee BioSolutions Corporation Information
    Table 55. Lee BioSolutions Description and Business Overview
    Table 56. Lee BioSolutions Human Antithrombin III Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2017-2022)
    Table 57. Lee BioSolutions Human Antithrombin III Product
    Table 58. Lee BioSolutions Recent Developments/Updates
    Table 59. ATryn Corporation Information
    Table 60. ATryn Description and Business Overview
    Table 61. ATryn Human Antithrombin III Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2017-2022)
    Table 62. ATryn Human Antithrombin III Product
    Table 63. ATryn Recent Developments/Updates
    Table 64. LFB Corporation Information
    Table 65. LFB Description and Business Overview
    Table 66. LFB Human Antithrombin III Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2017-2022)
    Table 67. LFB Human Antithrombin III Product
    Table 68. LFB Recent Developments/Updates
    Table 69. Shire Corporation Information
    Table 70. Shire Description and Business Overview
    Table 71. Shire Human Antithrombin III Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2017-2022)
    Table 72. Shire Human Antithrombin III Product
    Table 73. Shire Recent Developments/Updates
    Table 74. CSL Limited Corporation Information
    Table 75. CSL Limited Description and Business Overview
    Table 76. CSL Limited Human Antithrombin III Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2017-2022)
    Table 77. CSL Limited Human Antithrombin III Product
    Table 78. CSL Limited Recent Developments/Updates
    Table 79. Kedrion Corporation Information
    Table 80. Kedrion Description and Business Overview
    Table 81. Kedrion Human Antithrombin III Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2017-2022)
    Table 82. Kedrion Human Antithrombin III Product
    Table 83. Kedrion Recent Developments/Updates
    Table 84. Octapharma Corporation Information
    Table 85. Octapharma Description and Business Overview
    Table 86. Octapharma Human Antithrombin III Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2017-2022)
    Table 87. Octapharma Human Antithrombin III Product
    Table 88. Octapharma Recent Developments/Updates
    Table 89. Production Base and Market Concentration Rate of Raw Material
    Table 90. Key Suppliers of Raw Materials
    Table 91. Human Antithrombin III Distributors List
    Table 92. Human Antithrombin III Customers List
    Table 93. Human Antithrombin III Market Trends
    Table 94. Human Antithrombin III Market Drivers
    Table 95. Human Antithrombin III Market Challenges
    Table 96. Human Antithrombin III Market Restraints
    Table 97. Global Human Antithrombin III Sales Forecast by Form (2023-2028) & (K Bottles)
    Table 98. Global Human Antithrombin III Sales Market Share Forecast by Form (2023-2028)
    Table 99. Global Human Antithrombin III Revenue Forecast by Form (2023-2028) & (US$ Million)
    Table 100. Global Human Antithrombin III Revenue Market Share Forecast by Form (2023-2028)
    Table 101. Global Human Antithrombin III Sales Forecast by Application (2023-2028) & (K Bottles)
    Table 102. Global Human Antithrombin III Sales Market Share Forecast by Application (2023-2028)
    Table 103. Global Human Antithrombin III Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 104. Global Human Antithrombin III Revenue Market Share Forecast by Application (2023-2028)
    Table 105. Global Human Antithrombin III Sales Forecast by Region (2023-2028) & (K Bottles)
    Table 106. Global Human Antithrombin III Sales Market Share Forecast by Region (2023-2028)
    Table 107. Global Human Antithrombin III Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 108. Global Human Antithrombin III Revenue Market Share Forecast by Region (2023-2028)
    Table 109. Research Programs/Design for This Report
    Table 110. Key Data Information from Secondary Sources
    Table 111. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Human Antithrombin III
    Figure 2. Global Human Antithrombin III Market Share by Form in 2021 & 2028
    Figure 3. Lyophilized Form Product Picture
    Figure 4. Liquid Form Product Picture
    Figure 5. Global Human Antithrombin III Market Share by Application in 2021 & 2028
    Figure 6. Hmophilia
    Figure 7. Aplastic Anemia
    Figure 8. Heart Valve Disease
    Figure 9. Other
    Figure 10. Global Human Antithrombin III Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Human Antithrombin III Market Size (2017-2028) & (US$ Million)
    Figure 12. Global Human Antithrombin III Sales (2017-2028) & (K Bottles)
    Figure 13. Human Antithrombin III Sales Share by Manufacturers in 2021
    Figure 14. Global Human Antithrombin III Revenue Share by Manufacturers in 2021
    Figure 15. The Global 5 and 10 Largest Human Antithrombin III Players: Market Share by Revenue in 2021
    Figure 16. Human Antithrombin III Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 17. Global Human Antithrombin III Sales Market Share by Region (2017-2022)
    Figure 18. Global Human Antithrombin III Sales Market Share by Region in 2021
    Figure 19. Global Human Antithrombin III Revenue Market Share by Region (2017-2022)
    Figure 20. Global Human Antithrombin III Revenue Market Share by Region in 2021
    Figure 21. United States Human Antithrombin III Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Canada Human Antithrombin III Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. Germany Human Antithrombin III Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. France Human Antithrombin III Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. U.K. Human Antithrombin III Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Italy Human Antithrombin III Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Russia Human Antithrombin III Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. China Human Antithrombin III Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Japan Human Antithrombin III Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. South Korea Human Antithrombin III Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. India Human Antithrombin III Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Australia Human Antithrombin III Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. China Taiwan Human Antithrombin III Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Indonesia Human Antithrombin III Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Thailand Human Antithrombin III Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Malaysia Human Antithrombin III Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Mexico Human Antithrombin III Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Brazil Human Antithrombin III Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Argentina Human Antithrombin III Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Turkey Human Antithrombin III Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Saudi Arabia Human Antithrombin III Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. UAE Human Antithrombin III Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Sales Market Share of Human Antithrombin III by Form (2017-2022)
    Figure 44. Manufacturing Cost Structure of Human Antithrombin III
    Figure 45. Manufacturing Process Analysis of Human Antithrombin III
    Figure 46. Human Antithrombin III Industrial Chain Analysis
    Figure 47. Channels of Distribution
    Figure 48. Distributors Profiles
    Figure 49. Bottom-up and Top-down Approaches for This Report
    Figure 50. Data Triangulation
    Figure 51. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Grifols
Lee BioSolutions
ATryn
LFB
Shire
CSL Limited
Kedrion
Octapharma
Frequently Asked Questions
Human Antithrombin III report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Human Antithrombin III report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Human Antithrombin III report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

N Connectors

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More